Graziano, Robert F.,Gupta, Ashok K.,Kim, Su Young,Wigginton, Jon
申请号：
HRP20171788
公开号：
HRP20171788T1
申请日:
2017.11.17
申请国别(地区):
HR
年份:
2017
代理人:
摘要：
Provided herein are an anti-KIR antibody and an antibody that is selected from anti-PD-1 antibodies, anti-PD-L1 antibodies and anti-PD-L2 antibodies for use in treating cancer (e.g., advanced refractory solid tumors or hematological malignancies).
